1. Home
  2. LOB vs VERA Comparison

LOB vs VERA Comparison

Compare LOB & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Oak Bancshares Inc.

LOB

Live Oak Bancshares Inc.

HOLD

Current Price

$35.25

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$46.00

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOB
VERA
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
LOB
VERA
Price
$35.25
$46.00
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
$40.00
$67.67
AVG Volume (30 Days)
270.7K
1.8M
Earning Date
01-21-2026
11-05-2025
Dividend Yield
0.34%
N/A
EPS Growth
N/A
N/A
EPS
1.49
N/A
Revenue
$434,209,000.00
N/A
Revenue This Year
$44.86
N/A
Revenue Next Year
$16.20
N/A
P/E Ratio
$23.63
N/A
Revenue Growth
7.02
N/A
52 Week Low
$22.68
$18.53
52 Week High
$46.26
$47.74

Technical Indicators

Market Signals
Indicator
LOB
VERA
Relative Strength Index (RSI) 68.08 79.86
Support Level $32.63 $40.38
Resistance Level $33.30 $47.10
Average True Range (ATR) 0.97 3.15
MACD 0.47 1.28
Stochastic Oscillator 98.51 93.73

Price Performance

Historical Comparison
LOB
VERA

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: